Carregant...
M10. Pomaglumetad Methionil Normalizes Increased DA Neuron Activity in the VTA in the Methylazoxymethanol Acetate Developmental Disruption Model of Schizophrenia
Background: Our previous studies show that withdrawal from prior D2 antagonist treatment interferes with the ability of novel target compounds to reverse the hyperresponsive state of the DA system in the methylazoxymethanol acetate (MAM) model of schizophrenia; therefore we tested whether pomaglumet...
Guardat en:
| Publicat a: | Schizophr Bull |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475772/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx022.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|